Literature DB >> 25987797

Prevalence of fatty liver disease and the economy in China: A systematic review.

Jin-Zhou Zhu1, Qin-Yi Zhou1, Yu-Ming Wang1, Yi-Ning Dai1, Jiang Zhu1, Chao-Hui Yu1, You-Ming Li1.   

Abstract

AIM: To investigate the relationship between the economy and the adult prevalence of fatty liver disease (FLD) in mainland China.
METHODS: Literature searches on the PubMed and Chinese National Knowledge Infrastructure databases were performed to identify eligible studies published before July 2014. Records were limited to cross-sectional surveys or baseline surveys of longitudinal studies that reported the adult prevalence of FLD and recruited subjects from the general population or community. The gross domestic product (GDP) per capita was chosen to assess the economic status. Multiple linear regression and Loess regression were chosen to fit the data and calculate the 95%CIs. Fitting and overfitting of the models were considered in choosing the appropriate models.
RESULTS: There were 27 population-based surveys from 26 articles included in this study. The pooled mean prevalence of FLD in China was 16.73% (95%CI: 13.92%-19.53%). The prevalence of FLD was correlated with the GDP per capita and survey years in the country (adjusted R (2) = 0.8736, P GDP per capita = 0.00426, P years = 0.0000394), as well as in coastal areas (R (2) = 0.9196, P GDP per capita = 0.00241, P years = 0.00281). Furthermore, males [19.28% (95%CI: 15.68%-22.88%)] presented a higher prevalence than females [14.1% (95%CI: 11.42%-16.61%), P = 0.0071], especially in coastal areas [21.82 (95%CI: 17.94%-25.71%) vs 17.01% (95%CI: 14.30%-19.89%), P = 0.0157]. Finally, the prevalence was predicted to reach 20.21% in 2020, increasing at a rate of 0.594% per year.
CONCLUSION: This study reveals a correlation between the economy and the prevalence of FLD in mainland China.

Entities:  

Keywords:  Economy; Epidemiology; Fatty liver disease; Gross domestic product per capita; Prevalence

Mesh:

Year:  2015        PMID: 25987797      PMCID: PMC4427696          DOI: 10.3748/wjg.v21.i18.5695

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  34 in total

1.  Prevalence of diabetes among men and women in China.

Authors:  Wenying Yang; Juming Lu; Jianping Weng; Weiping Jia; Linong Ji; Jianzhong Xiao; Zhongyan Shan; Jie Liu; Haoming Tian; Qiuhe Ji; Dalong Zhu; Jiapu Ge; Lixiang Lin; Li Chen; Xiaohui Guo; Zhigang Zhao; Qiang Li; Zhiguang Zhou; Guangliang Shan; Jiang He
Journal:  N Engl J Med       Date:  2010-03-25       Impact factor: 91.245

2.  [Guidelines for diagnosis and treatment of nonalcoholic fatty liver diseases].

Authors: 
Journal:  Zhonghua Gan Zang Bing Za Zhi       Date:  2006-03

Review 3.  The metabolic syndrome.

Authors:  Marc-Andre Cornier; Dana Dabelea; Teri L Hernandez; Rachel C Lindstrom; Amy J Steig; Nicole R Stob; Rachael E Van Pelt; Hong Wang; Robert H Eckel
Journal:  Endocr Rev       Date:  2008-10-29       Impact factor: 19.871

4.  Guidelines for the diagnosis and treatment of alcoholic liver disease.

Authors:  Min De Zeng; You Ming Li; Cheng Wei Chen; Lun Gen Lu; Jian Gao Fan; Bing Yuan Wang; Yi Min Mao
Journal:  J Dig Dis       Date:  2008-05       Impact factor: 2.325

5.  Prevalence of and risk factors for fatty liver in a general population of Shanghai, China.

Authors:  Jian-Gao Fan; Jun Zhu; Xing-Jian Li; Lan Chen; Lui Li; Fei Dai; Feng Li; Shi-Yao Chen
Journal:  J Hepatol       Date:  2005-09       Impact factor: 25.083

6.  Utility of a new model to diagnose an alcohol basis for steatohepatitis.

Authors:  Winston Dunn; Paul Angulo; Schuyler Sanderson; Laith H Jamil; Linda Stadheim; Charles Rosen; Michael Malinchoc; Patrick S Kamath; Vijay H Shah
Journal:  Gastroenterology       Date:  2006-08-10       Impact factor: 22.682

7.  How common is non-alcoholic fatty liver disease in the Asia-Pacific region and are there local differences?

Authors:  Deepak N Amarapurkar; Estsuko Hashimoto; Laurentius A Lesmana; José D Sollano; Pei-Jer Chen; Khean-Lee Goh
Journal:  J Gastroenterol Hepatol       Date:  2007-06       Impact factor: 4.029

Review 8.  Epidemiology of non-alcoholic fatty liver disease in China.

Authors:  Jian-Gao Fan; Geoffrey C Farrell
Journal:  J Hepatol       Date:  2008-11-06       Impact factor: 25.083

9.  Prevalence of fatty liver disease and its risk factors in the population of South China.

Authors:  Yong-Jian Zhou; Yu-Yuan Li; Yu-Qiang Nie; Jin-Xiang Ma; Lun-Gen Lu; Sheng-Li Shi; Min-Hu Chen; Pin-Jin Hu
Journal:  World J Gastroenterol       Date:  2007-12-21       Impact factor: 5.742

10.  Prevalence and risk factors of fatty liver disease in the Shuiguohu district of Wuhan city, central China.

Authors:  Zhongli Wang; Bing Xia; Chunwei Ma; Zhengguo Hu; Xiangqun Chen; Ping Cao
Journal:  Postgrad Med J       Date:  2007-03       Impact factor: 2.401

View more
  22 in total

Review 1.  Nonalcoholic fatty liver disease in Asia: emerging perspectives.

Authors:  Wai-Kay Seto; Man-Fung Yuen
Journal:  J Gastroenterol       Date:  2016-09-16       Impact factor: 7.527

2.  The measurement of liver fat from single-energy quantitative computed tomography scans.

Authors:  Xiaoguang Cheng; Glen M Blake; J Keenan Brown; Zhe Guo; Jun Zhou; Fengzhe Wang; Liqiang Yang; Xiaohong Wang; Li Xu
Journal:  Quant Imaging Med Surg       Date:  2017-06

3.  Impact of living donor liver with steatosis and idiopathic portal inflammation on clinical outcomes in pediatric liver transplantation: Beijing experience.

Authors:  Yafei He; Xinyan Zhao; Jimin Liu; Qian Zhang; Liwei Liu; Wei Qu; Ying Liu; Zhigui Zeng; Haiming Zhang; Jidong Jia; Liying Sun; Lin Wei; Zhijun Zhu
Journal:  Hepatobiliary Surg Nutr       Date:  2022-06       Impact factor: 8.265

4.  The Morbidity and Comorbidity of Nonalcoholic Fatty Liver Disease and Different Glucose Intolerance Strata in a Community-Based Chinese Population.

Authors:  Xiuying Zhang; Xianghai Zhou; Xueyao Han; Zuodi Fu; Lianying Wang; Yufeng Li; Linong Ji
Journal:  Metab Syndr Relat Disord       Date:  2020-05-27       Impact factor: 1.894

5.  Serum periostin is a potential biomarker for non-alcoholic fatty liver disease: a case-control study.

Authors:  Jin-Zhou Zhu; Hua-Tuo Zhu; Yi-Ning Dai; Chun-Xiao Li; Zhi-Yun Fang; De-Jian Zhao; Xing-Yong Wan; Yu-Ming Wang; Fang Wang; Chao-Hui Yu; You-Ming Li
Journal:  Endocrine       Date:  2015-09-11       Impact factor: 3.633

6.  Association between body mass index and fatty liver risk: A dose-response analysis.

Authors:  Rui Fan; Jufang Wang; Jinman Du
Journal:  Sci Rep       Date:  2018-10-15       Impact factor: 4.379

7.  A juvenile case with nonalcoholic steatohepatitis and traditional Korean medicine-based treatment.

Authors:  Chang-Gue Son
Journal:  Integr Med Res       Date:  2018-02-02

8.  Estimation of the Prevalence of Nonalcoholic Fatty Liver Disease in an Adult Population in Northern China Using the Data Mining Approach.

Authors:  TengFei Yang; Bo Zhao; Dongmei Pei
Journal:  Diabetes Metab Syndr Obes       Date:  2021-07-28       Impact factor: 3.168

9.  Determinants of basic public health services provision by village doctors in China: using non-communicable diseases management as an example.

Authors:  Tongtong Li; Trudy Lei; Zheng Xie; Tuohong Zhang
Journal:  BMC Health Serv Res       Date:  2016-02-04       Impact factor: 2.655

10.  Dyslipidemia in rural areas of North China: prevalence, characteristics, and predictive value.

Authors:  Nannan Gao; Yong Yu; Bingchang Zhang; Zhongshang Yuan; Haiqing Zhang; Yongfeng Song; Meng Zhao; Jiadong Ji; Lu Liu; Chao Xu; Jiajun Zhao
Journal:  Lipids Health Dis       Date:  2016-09-13       Impact factor: 3.876

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.